| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/03/2002 | EP0833661B1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/03/2002 | EP0779366B1 Process for producing optically active 1-halo-3-amino-4-phenyl-2-butanol derivatives |
| 04/03/2002 | EP0775199B1 Superoxide dismutase-4 |
| 04/03/2002 | EP0736002B1 Compound capable of introducing at least one molecule into a cell |
| 04/03/2002 | EP0722489B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 04/03/2002 | CN1343125A Immunostimulant bacterial membrane tractions in cancer treatment |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1082092C Process for producing substance |
| 04/02/2002 | US6365802 Methods for increasing stearate content in soybean oil |
| 04/02/2002 | US6365799 Hygromycin-resistant transgenic plants |
| 04/02/2002 | US6365757 Culturing tissues of taxus wallichiania; isolation by partitioning the culture product residue, obtained by polar solvent extraction; desolventizing between water and chlorinated solvents; evaporation; chromotography; adsorption; |
| 04/02/2002 | US6365571 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient |
| 04/02/2002 | US6365410 Culturing microorganism with a heterologous mutator gene having an increased mutation rate for at least 20 doublings under selective conditions, then restoring resultant microorganism to wild type mutation rate; biosynthesis |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365388 Biotin biosynthetic genes |
| 04/02/2002 | US6365386 Polynucleotide which codes for enzyme that converts beta-carotene to astaxanthin |
| 04/02/2002 | US6365384 Method for disposing waste |
| 04/02/2002 | US6365382 Contacting a 6'-h analogue of a specific formula for hydroxylation with a amycolatopsis orientalis microorganism; preparation of anticholesterol agents |
| 04/02/2002 | US6365380 Method for stereoselectively inverting a chiral center of a chemical compound using an enzyme and a metal catalyst |
| 04/02/2002 | US6365361 Method for identifying or screening agonist and antagonist to PPAR |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2124214C Materials and methods for biosynthesis of serine and serine-related products |
| 04/02/2002 | CA2101273C Arachidonic acid and methods for the production and use thereof |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/28/2002 | WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation |
| 03/28/2002 | WO2002024879A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | WO2001087062A3 Microinjection of cryoprotectants for preservation of cells |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 03/28/2002 | US20020038471 Use of VLCFAE for identifying herbicidally active compounds |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037586 Propagating preferential aggregates in nutrient broth; obtain aggregate, hold in preferential position, supply with nutrients, propagate aggregates, recover aggreagtes |
| 03/28/2002 | US20020037577 Microorganisms for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037573 Enzymatic protein for use in the generation of preferential protein complex |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037562 By cultivating a bacterium harboring a DNA coding for actohydroxy acid synthase isozime III originating from Escherichia coli which is free from inhibition by L-valine and has specified other properties; DNA |
| 03/28/2002 | US20020037561 Method for producing arachidonic acid |
| 03/28/2002 | US20020037559 Microorganism which can utilize an N-protected proline derivative of given general formula in the form of the racemate or an optically active isomer; simplification; N-acyl-L-proline acylase |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037547 Process for the fermentative production of deacylated cephalosporins |
| 03/28/2002 | US20020037535 Contacting the cells (other than cancer cells and megakaryocyte progenitor cells) with a modified C-reactive protein or a mutant or mutant, modified C-reactive protein; in vitro or in vivo; |
| 03/28/2002 | US20020037342 Multi-enzyme product with glucoamylase, proteolytic and xylanase activities and method for producing same by solid state fermentation of wheat bran with aspergillus niger |
| 03/28/2002 | US20020037291 Sphingoglycolipid |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | CA2423161A1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours |
| 03/27/2002 | EP1191707A1 Power amplifier sharing in a wireless communication system with transmit diversity |
| 03/27/2002 | EP1191109A1 Molecular methods for detecting guar gum additions to locust bean gum |
| 03/27/2002 | EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren |
| 03/27/2002 | EP1190096A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
| 03/27/2002 | EP1190087A1 Hydroxylation of compactin to pravastatin by micromonospora |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190064A1 Vectors, cells and processes for pyrimidine deoxyribonucleosides production |
| 03/27/2002 | EP1190062A1 Avirulent xanthomonas-campestris strains producing xanthan |
| 03/27/2002 | EP1190048A2 Novel candida albicans genes and proteins coded by said genes |
| 03/27/2002 | EP1190038A2 Bacterial protection against stress |
| 03/27/2002 | EP1189935A1 Extraction of integral membrane proteins |
| 03/27/2002 | EP1189908A1 Indolocarbazole alkaloids from a marine actinomycete |
| 03/27/2002 | EP1189843A1 Bioremediation of petroleum pollutants with alkane-utilizing bacteria |
| 03/27/2002 | EP1189627A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 03/27/2002 | EP1077068B1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 03/27/2002 | EP0904339B1 Sterol extraction with a polar solvent to give low sterol microbial oil |
| 03/27/2002 | EP0831906B1 Treatment of t cell mediated autoimmune disorders |
| 03/27/2002 | EP0782452B1 Cell growth regulator |
| 03/27/2002 | EP0733123B1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/27/2002 | EP0712442B1 Vaccine compositions |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/27/2002 | CN1342199A Subtilase enzymes of I-S1 and I-S2 sub-groups having additional amino acid residue in active site loop region |
| 03/27/2002 | CN1342196A Bifidobacterium in treatment of inflammatory disease |
| 03/27/2002 | CN1342155A Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 03/27/2002 | CN1341715A Production method of novel mutant N-acetylglutamate synthetase and L-arginine |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362316 Human metabotropic glutamate receptor subtype mGluR6 protein |
| 03/26/2002 | US6362168 Antiparasitic agents |
| 03/26/2002 | US6362007 For diagnosis and therapy of systemic lupus erythematosus and related diseases, and diseases in which epstein-barr virus has been implicated |
| 03/26/2002 | US6361986 For fermentation using corynebacteria in which the accda gene is amplified |
| 03/26/2002 | US6361981 Enzyme hydrolysis of (meth)acrylonitrile |
| 03/26/2002 | US6361979 Oxidation using microorganism |
| 03/26/2002 | US6361978 Production of biotin |
| 03/26/2002 | US6361970 A polypeptide encoding an isoleucyl trna synthetase; therapy and screening antibiotic compounds |
| 03/26/2002 | US6361966 Screening escherichia mutant cells resistant to over-expression toxicity by culturing the transformed cells with an expression vector, induce expression for a toxic effect and select viable cells |
| 03/26/2002 | US6361946 A bone marrow modulating method in mammals by adminstering a polypeptide that binds to at least one endothelial cell surface receptor to modulates myelopoiesis |
| 03/26/2002 | US6361778 Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles |
| 03/26/2002 | CA2160262C Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities |
| 03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
| 03/26/2002 | CA2055698C Peroxidase gene of microbial origin |
| 03/21/2002 | WO2002022849A2 Enzymatic resolution of aryl- and thio-substituted acids |
| 03/21/2002 | WO2002022848A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | WO2002022845A1 Process for preparing n-substituted 4-hydroxypiperidines by enzymatic hydroxylation |
| 03/21/2002 | WO2002022785A1 Improvements in or relating to selective agents for biological cultures |